US FDA Struggling With Long-Term Follow-Up Requirements For Gene Therapies

 
• By Derrick Gingery
long-term
Many data collection hurdles could arise in the 15-year follow-up period for gene therapy patients. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies